高级检索
    张嘉涛, 钟文昭. 阿来替尼新辅助治疗ALK阳性Ⅱ~Ⅲ期非小细胞肺癌患者：评NAUTIKA1伞式研究[J]. 循证医学, 2023, 23(1): 26-29. DOI: 10.12019/j.issn.1671-5144.2023.01.005
    引用本文: 张嘉涛, 钟文昭. 阿来替尼新辅助治疗ALK阳性Ⅱ~Ⅲ期非小细胞肺癌患者：评NAUTIKA1伞式研究[J]. 循证医学, 2023, 23(1): 26-29. DOI: 10.12019/j.issn.1671-5144.2023.01.005
    shu
    ZHANG Jia-tao, ZHONG Wen-zhao. Neoadjuvant Alectinib for ALK+ Stage Ⅱ~Ⅲ Non-Small Cell Lung Cancer: Analysis of NAUTIKA1 Study[J]. Journal of Evidence-Based Medicine, 2023, 23(1): 26-29. DOI: 10.12019/j.issn.1671-5144.2023.01.005
    Citation: ZHANG Jia-tao, ZHONG Wen-zhao. Neoadjuvant Alectinib for ALK+ Stage Ⅱ~Ⅲ Non-Small Cell Lung Cancer: Analysis of NAUTIKA1 Study[J]. Journal of Evidence-Based Medicine, 2023, 23(1): 26-29. DOI: 10.12019/j.issn.1671-5144.2023.01.005
    shu

    阿来替尼新辅助治疗ALK阳性Ⅱ~Ⅲ期非小细胞肺癌患者：评NAUTIKA1伞式研究

    Neoadjuvant Alectinib for ALK+ Stage Ⅱ~Ⅲ Non-Small Cell Lung Cancer: Analysis of NAUTIKA1 Study

      摘要
      • HTML全文
      • 参考文献(7)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回